Drug intelligence / Profile preview

Melaniq

Development stage
Unknown
Lead developer
Oxford Biolabs
Modality
Small Molecules
Administration
Oral
01

Overview

Melaniq is a multi-ingredient nutraceutical supplement developed by Oxford Biolabs Ltd. (also known as L.R. Research) specifically formulated to support natural hair pigmentation and address the underlying causes of hair graying. The product's mechanism of action involves providing essential precursors and enzymatic cofactors required for melanogenesis, the process of melanin production in hair follicles. Key ingredients include L-tyrosine, a direct precursor to melanin, and copper, which serves as a vital cofactor for the enzyme tyrosinase. Additionally, Melaniq contains catalase, an enzyme that helps neutralize hydrogen peroxide—a metabolic byproduct known to accumulate in hair follicles and bleach hair from the inside out. The formulation is supplemented with vitamins such as biotin, B12, and D3 to support overall hair health. It is marketed as a non-pharmaceutical consumer product for individuals experiencing premature graying or looking to maintain their natural hair color.

Brand names
Melaniq
Other names
Melaniq Hair Pigmentation Supplement
02

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on Melaniq.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melaniq.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call